Fasenra pen 30 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26FQS3B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,578
Award facts
- Contract value 100% obligated
- $21,577.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,577.50 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Fasenra Pen 30 mg/ml, a pharmaceutical product used in the treatment of eosinophilic asthma and other eosinophil-driven conditions. This non-set-aside contract is scheduled for completion by January 8, 2026, with performance centered at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply procurement supporting military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, was competitively selected to fulfill this requirement based on its established capabilities in delivering specialized medications and medical supplies across therapeutic domains. The company's extensive federal contract portfolio with the DLA demonstrates consistent performance in supplying brand-name and generic pharmaceuticals, vaccines, and medical devices to support Defense Health Agency operations and other government healthcare systems worldwide. This award reflects the company's role as a key pharmaceutical prime vendor within the federal supply chain infrastructure serving military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FQS3B?
SPE2DR26FQS3B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FQS3B worth?
The government has obligated $21,578 on SPE2DR26FQS3B.
Is contract SPE2DR26FQS3B an order under another contract?
Yes. SPE2DR26FQS3B is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQS3B competed?
The extent of competition for SPE2DR26FQS3B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award